William Hatcher1, Britten Pund1, Giorgi Khatiashvili1. 1. William Hatcher and Giorgi Khatiashvili are with Augusta University, Augusta, GA. Britten Pund is with the National Alliance of State & Territorial AIDS Directors, Washington, DC.
Abstract
OBJECTIVES: To examine President Obama's fiscal commitment to the Ryan White Program (formerly Ryan White Comprehensive AIDS Resource Emergency Act), which provides funding for economically disadvantaged people and families affected by HIV. METHODS: We analyzed budgetary request and congressional appropriation data from 2009 to 2016. The data are available from the Health Resources and Services Administration and the Henry J. Kaiser Family Foundation. RESULTS: Increased coverage for people living with HIV/AIDS provided by the Affordable Care Act most likely led the Obama administration to request small increases and at times decreases in funding for the Ryan White Program. Congress passed either small increases or decreases in appropriations for the Ryan White Program. CONCLUSIONS: Decreases or small increases in the Ryan White Program funding risk progress made in treating HIV among economically disadvantaged patients.
OBJECTIVES: To examine President Obama's fiscal commitment to the Ryan White Program (formerly Ryan White Comprehensive AIDS Resource Emergency Act), which provides funding for economically disadvantaged people and families affected by HIV. METHODS: We analyzed budgetary request and congressional appropriation data from 2009 to 2016. The data are available from the Health Resources and Services Administration and the Henry J. Kaiser Family Foundation. RESULTS: Increased coverage for people living with HIV/AIDS provided by the Affordable Care Act most likely led the Obama administration to request small increases and at times decreases in funding for the Ryan White Program. Congress passed either small increases or decreases in appropriations for the Ryan White Program. CONCLUSIONS: Decreases or small increases in the Ryan White Program funding risk progress made in treating HIV among economically disadvantaged patients.